Truvian Health’s device, TruVerus, processes routine blood tests in less than 30 minutes outside traditional labs and has earned FDA clearance.

As scientists race to develop simple blood tests that could one day act as an early warning system for Alzheimer’s disease by sounding the alarm before memory problems appear, new research shows ...

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic ...

Researchers have unveiled a breakthrough non-invasive tool that can estimate a person’s biological age using a simple urine sample, potentially transforming the way ageing and disease risks are ...

Families with young children are being invited to take part in a UKHSA study on childhood lead exposure using home testing ...

Ash provides the at-home testing operational backbone for Noom’s new Proactive Health Microdose GLP-1Rx Program ...

Households in one part of the UK have been sent letters in the post to ask them to take part in a study on possible lead ...

The At-Home Syphilis Testing Market is projected to grow from USD 432.4 million in 2025 to a substantial USD 1,245.6 million by ...

New program pairs microdoses of GLP-1 medication with Noom's powerful behavior-change program and at-home biomarker testing to track the health impact of combining GLP-1 therapy with healthy habits.

Rapid test for flu and other respiratory ailments makes it easy to avoid long queues, showcases Chinese economy's consumption ...

The advertising watchdog exposed one ad for suggesting patients could “skip the doctors” with an at-home PSA test ...

The Advertising Standards Authority said misleading claims could give false reassurance or make it harder to know when to ...